AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Spanish Registry of Patients With IgM Monoclonal Gammopathies

Recruitingn/aAges 18 Years - anyAllFundación Española de Hematología y Hemoterapía
💬

In plain words

What the trial is, and whether it could suit you

Waldenström's macroglobulinemia (WM) is a B-cell lymphoproliferative disorder which is defined by bone marrow infiltration by small lymphocytes, lymphoplasmacytoid and plasma cells together with the presence of a detectable monoclonal immunoglobulin M (IgM).The clinical presentation of WM is variable. Symptoms can be related to tumor infiltration, or they can be related to the monoclonal IgM component. The therapeutic options are heterogeneous and there are no well-established in both first line or relapse/refractory settings. In Spain, the incidence of MGUS-IgM and WM in the last decade is unknown. The aims of this retrospective, observational, multicentric study is: * To develop a national registry of patients diagnosed with Waldenström's Macroglobulinemia and Monoclonal Gammopathy of uncertain significance -IgM in Spain in the past 30years. * To evaluate the most relevant clinical c

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥18 years * Patients having a confirmed diagnosis of either in the las 30 years: * Monoclonal Gammopathy of uncertain significance -IgM * Asymptomatic Waldenström's macroglobulinemia * Symptomatic Waldenström's macroglobulinemia Exclusion Criteria: * Other subtypes of Lymphoproliferative diseases.
💊

What it tests

  • Not listed
📍

Where

51 sites
Hospital de Mérida
Mérida, Spain
Hospital Son Llatzer
Palma, Spain
Hospital Universitario Son Espases
Palma de Mallorca, Spain
ICO Badalona - Hospital Germans Trias i Pujol
Badalona, Spain
Hospital Mutua Terrassa
Barcelona, Spain
Hospital de San Juan Despí Moisès Broggi
Barcelona, Spain
Hospital Clínic de Barcelona
Barcelona, Spain
Hospital del Mar
Barcelona, Spain

…and 43 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy